Literature DB >> 27890624

Mitochondrial cAMP prevents apoptosis modulating Sirt3 protein level and OPA1 processing in cardiac myoblast cells.

Anna Signorile1, Arcangela Santeramo2, Grazia Tamma3, Tommaso Pellegrino3, Susanna D'Oria4, Paolo Lattanzio5, Domenico De Rasmo5.   

Abstract

Mitochondria, responding to a wide variety of signals, including oxidative stress, are critical in regulating apoptosis that plays a key role in the pathogenesis of a variety of cardiovascular diseases. A number of mitochondrial proteins and pathways have been found to be involved in the mitochondrial dependent apoptosis mechanism, such as optic atrophy 1 (OPA1), sirtuin 3 (Sirt3), deacetylase enzyme and cAMP signal. In the present work we report a network among OPA1, Sirt3 and cAMP in ROS-dependent apoptosis. Rat myoblastic H9c2 cell lines, were treated with tert-butyl hydroperoxide (t-BHP) to induce oxidative stress-dependent apoptosis. FRET analysis revealed a selective decrease of mitochondrial cAMP in response to t-BHP treatment. This was associated with a decrease of Sirt3 protein level and proteolytic processing of OPA1. Pretreatment of cells with permeant analogous of cAMP (8-Br-cAMP) protected the cell from apoptosis preventing all these events. Using H89, inhibitor of the protein kinase A (PKA), and protease inhibitors, evidences have been obtained that ROS-dependent apoptosis is associated with an alteration of mitochondrial cAMP/PKA signal that causes degradation/proteolysis of Sirt3 that, in turn, promotes acetylation and proteolytic processing of OPA1.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apoptosis; Mitochondria; OPA1; Sirt3; cAMP

Mesh:

Substances:

Year:  2016        PMID: 27890624     DOI: 10.1016/j.bbamcr.2016.11.022

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  20 in total

Review 1.  Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology.

Authors:  Stephanie M Adaniya; Jin O-Uchi; Michael W Cypress; Yoichiro Kusakari; Bong Sook Jhun
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-13       Impact factor: 4.249

Review 2.  Recent advances in, and challenges of, designing OMA1 drug screens.

Authors:  Marcel V Alavi
Journal:  Pharmacol Res       Date:  2022-01-07       Impact factor: 7.658

3.  Oxygen-Glucose Deprivation/Reperfusion-Induced Sirt3 Reduction Facilitated Neuronal Injuries in an Apoptosis-Dependent Manner During Prolonged Reperfusion.

Authors:  Rongqi Wan; Jiahui Fan; Huimeng Song; Wei Sun; Yanling Yin
Journal:  Neurochem Res       Date:  2022-01-29       Impact factor: 3.996

4.  Impact of atypical mitochondrial cyclic-AMP level in nephropathic cystinosis.

Authors:  Francesco Bellomo; Anna Signorile; Grazia Tamma; Marianna Ranieri; Francesco Emma; Domenico De Rasmo
Journal:  Cell Mol Life Sci       Date:  2018-03-16       Impact factor: 9.261

Review 5.  Acetylation of Mitochondrial Proteins in the Heart: The Role of SIRT3.

Authors:  Rebecca M Parodi-Rullán; Xavier R Chapa-Dubocq; Sabzali Javadov
Journal:  Front Physiol       Date:  2018-08-07       Impact factor: 4.566

6.  Increased Levels of cAMP by the Calcium-Dependent Activation of Soluble Adenylyl Cyclase in Parkin-Mutant Fibroblasts.

Authors:  Paola Tanzarella; Anna Ferretta; Simona Nicol Barile; Mariella Ancona; Domenico De Rasmo; Anna Signorile; Sergio Papa; Nazzareno Capitanio; Consiglia Pacelli; Tiziana Cocco
Journal:  Cells       Date:  2019-03-15       Impact factor: 6.600

7.  Mitochondrial Effects of Teucrium Polium and Prosopis Farcta Extracts in Colorectal Cancer Cells

Authors:  Forouzan Khodaei; Kiyanoosh Ahmadi; Hamze Kiyani; Mahmoud Hashemitabar; Mohsen Rezaei
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27

Review 8.  SIRT3: A New Regulator of Cardiovascular Diseases.

Authors:  Wei Sun; Caixia Liu; Qiuhui Chen; Ning Liu; Youyou Yan; Bin Liu
Journal:  Oxid Med Cell Longev       Date:  2018-02-13       Impact factor: 6.543

9.  PBMC of Multiple Sclerosis Patients Show Deregulation of OPA1 Processing Associated with Increased ROS and PHB2 Protein Levels.

Authors:  Domenico De Rasmo; Anna Ferretta; Silvia Russo; Maddalena Ruggieri; Piergiorgio Lasorella; Damiano Paolicelli; Maria Trojano; Anna Signorile
Journal:  Biomedicines       Date:  2020-04-11

Review 10.  Functional Significance of the Adcy10-Dependent Intracellular cAMP Compartments.

Authors:  Sofya Pozdniakova; Yury Ladilov
Journal:  J Cardiovasc Dev Dis       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.